DJIA 17,826.30 -279.47 -1.54%
NASDAQ 4,931.82 -75.98 -1.52%
S&P 500 2,081.18 -23.81 -1.13%
market minute promo

64.91 1.42 (2.24%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

TEVA $64.91 2.24%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $62.36
Previous Close $63.49
Daily Range $62.24 - $66.97
52-Week Range $47.36 - $68.75
Market Cap $55.3B
P/E Ratio 42.61
Dividend (Yield) $1.36 (1.8%)
Ex-Dividend Date
Dividend Pay Date
02/17/15
03/03/15
Volume 15,721,083
Average Daily Volume 5,620,000
Current FY EPS $5.17

Sector

Healthcare

Industry

Drug Makers

Teva Pharmaceutical Industries (TEVA) Description

A global pharmaceutical company, Teva develops, produces, and markets generic drugs covering all major treatment categories. Website: http://www.tevapharm.com/

News & Commentary Rss Feed

3 Top Healthcare Stocks Surging Higher This Year

Eagle Pharmaceuticals Inc., Esperion Therapeutics Inc., and Horizon Pharma plc have more than doubled investors' money this year.

Novartis and Momenta Get FDA Nod For Generic Copaxone - Analyst Blog

Teva Pharmaceuticals (TEVA) Stock Gains Today on Mylan Takeover Talk

Mylan: There's No Logic The Teva Merger Rumor

Trade-Ideas: Teva Pharmaceutical Industries (TEVA) Is Today's "Barbarian At The Gate" Stock

Mylan Scores Final Win In Patent Challenge On Inhalation Drug

VIVUS Responds to Teva's Filing for Qsymia Generics - Analyst Blog

Why Momenta Pharmaceuticals Inc. Shares Are Surging Higher

The FDA has approved Novartis and Momenta Pharmaceuticals, Inc.'s biosimilar to Teva Pharmaceuticals Copaxone.

Momenta Pharmaceuticals Spikes Up Following FDA News On Copaxone

Teva Pharmaceutical Industries (TEVA) Showing Signs Of Being Water-Logged And Getting Wetter

See More TEVA News...

TEVA's Top Competitors

TEVA $64.91 (2.24%)
Current stock: TEVA
JNJ $99.58 (-0.21%)
Current stock: JNJ
NVS $102.46 (-0.82%)
Current stock: NVS
RHHBY $35.44 (-1.53%)
Current stock: RHHBY